Clinical Trials in Denver

Showing 7061-7080 of 18,161 trials

The Prevalence of Oral HPV Infection and Oral Lesions in People Living With HIV

NCT06205511

The study will evaluate 300 people living with HIV that attend the Vivent Clinic for HIV care. We will characterize our population and include age, race/ethnicity, sex at birth, tobacco use, alcohol use, other comorbidities, HPV vaccination status, other HPV disease, and lab values such as CD4 count and HIV viral load. We will compare results between participants who are HPV positive and negative. We will also evaluate the relationship between HPV oral infections and lesions and the variables above to better understand possible predictors of HPV infections and lesions.

Human Immunodeficiency VirusHuman Papilloma Virus

Vivent Health300 participantsStarted Apr 2023

Denver, Colorado, United States

COMPLETEDPhase 25.0 miles

B0151005 Open-Label Extension Study

NCT01345318

This is a multi-center Phase 2, open label, safety extension study in subjects with moderate to severe CD who are anti-TNF inadequate responders. Subjects eligible for this study will have completed the 12-week induction period of study B0151003 and will be enrolled as either responders or non responders.

Crohn's Disease

Pfizer191 participantsStarted Jun 2011

Scottsdale, Arizona, United States • Scottsdale, Arizona, United States • Tucson, Arizona, United States +124 more locations

The Prevalence of Oral HPV Infection and Oral Lesions in People Living With HIV

B0151005 Open-Label Extension Study

Find Trials by Condition in Denver

Clostridium Difficile Vaccine 2-Dose Versus 3-Dose Study

A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis

A Study of PTC923 in Participants With Phenylketonuria

An Interventional Safety Switch Study (Segue Study) of XYWAV in Narcolepsy

Diagnostic Performance of Small RNA Blood Test in Patients Undergoing Follow-up Imaging After Positive Low Dose CT Screening for Cancer of the Lung

Congenital Heart Disease: Impact on Learning and Development in Down Syndrome (CHILD-DS)

Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid Arthritis

Clinical Research Study With Clazosentan to Evaluate Its Effects on Preventing Complications Due to the Narrowing of the Blood Vessels (Vasospasm) in the Brain, Caused by Bleeding Onto the Surface of the Brain

Comparison of Participants Who Received a CanGaroo® Envelope, TYRX™ Envelope, or no Envelope During CIED Implantation

A Study of OV101 in Individuals With Angelman Syndrome (AS)

Study to Evaluate the Effects of RO7496998 (AT-527) in Non-Hospitalized Adult and Adolescent Participants With Mild or Moderate COVID-19

A Study to EXhibit Percutaneous Coronary Artery Dilatation With Non-Slip Element Balloon

Antigen-specific T Cell Therapy for AML or MDS Patients With Relapsed Disease After Allo-HCT

A Study of LY3457263 Alone and in Combination With Dulaglutide (LY2189265) in Participants With Type 2 Diabetes

Alleviation of Common Cold Symptoms

Study Evaluating Betrixaban in Pediatric Participants

A Phase I/II Study of MLN0128 in Metastatic Anaplastic Thyroid Cancer and Incurably Poorly Differentiated or Radioidodine Refractory Differentiated Thyroid Cancer

The Half Moon Transcatheter Mitral Valve Repair (TMVr) Pilot Study